Pfizer to Buy Metsera for $4.9 Billion in Obesity Drug Bet In a strategic move to revamp its position in the obesity drug market, pharmaceutical giant Pfizer Inc. has announced its acquisition of the startup company Metsera Inc. The deal, valued at a substantial $4.9 billion, signifies Pfizer’s commitment to gaining ground in the highly […]
Category: Retail Healthcare
Back To Top